Study design and implementation of the PRecision Medicine In MEntal health Care (PRIME Care) Trial

Genomic testing has the potential to improve patient outcomes and reduce patient care costs by personalizing medication selection. Commercial pharmacogenetic (PGx) testing for psychotropic and other medications is widely available and promoted as a means to implement “precision medicine.” Despite evidence that genetic variation affects the metabolism of psychotropic medications, the clinical utility of these test results has not been established. Moreover, implementing such testing in routine clinical care is complex, requiring informatics support and a syst ematic approach to patient and provider education.

Source: Contemporary Clinical Trials - December 10, 2020 Category: Radiology Authors: David W. Oslin, Sara Chapman, Scott L. Duvall, Joel Gelernter, Erin Ingram, Henry R. Kranzler, Lisa Soleymani Lehmann, Julie A. Lynch, Kevin G. Lynch, Jeff M. Pyne, Mei-Chiung Shih, Annjanette Stone, Michael E. Thase, Laura O. Wray Source Type: research